Sodium Iodide I 131 Diagnostic Capsule
Product Images NDC 65174-461

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sodium Iodide I 131 Diagnostic (NDC 65174-461). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jubilant Draximage Inc., Dba Jubilant Radiopharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Capsule 3.7 (Image1)

FDA Label Image

Capsule 3.7 (Image2)

Capsule 3.7 (Image2)
This text appears to be a description of a radioactive medication labeled with lot number 502461, to be used only by prescription (Rx only). The medication is in capsule form and contains 3.7 MBq (100 LCi) of SODIUM IODIDE-131 for diagnostic thyroid imaging and function studies. The calibration dosage is 0.185103.7 MBq and it should be stored between 16 and 30° Celsius (60.8 and 86° Fahrenheit). The capsules are color-coded yellow and the activity level is 18.5 MBq (500 µCi). The expiration date is not stated, but the half-life of I-131 is given as 8.04 days. The correct dosage can be calculated using a color-coded decay calendar. The manufacturer is Jubilant Draximage Inc. with a mailing address of 510804 Kirkland Québec HOH 4J4 Canada.*
FDA Label Image

Capsule 3.7 (Image3)

Capsule 3.7 (Image3)
This is information related to a radioactive material, specifically Iodine-131, which comes in capsules of 3.7 MBq (100 Ci) and 18.5 MBq (500 iCi). The calibration and expiration dates are also included. The half-life of I-131 is 8.04 days, and the specific activity has no carrier added. The text states a warning of caution due to the radioactive nature of the material.*
FDA Label Image

Capsule 3.7 (Image4)

Capsule 3.7 (Image4)
This is a description of a radioactive material that comes in the form of 5 capsules. Each capsule contains 3.7 MBq (100 Ci) of the material, with a total activity of 8.5 MBq (500 Ci) across all capsules. The half-life of the material is 8.04 days and no carrier is added to the material. The text also includes a caution as it is a radioactive substance.*
FDA Label Image

Capsule 3.7 (Image5)

Capsule 3.7 (Image5)
This text is a description of a radioactive medical capsule named Sodium Iodide 131. It has a specific half-life of 8.04 days, and each capsule contains 3.7 MBq (100 Ci) of activity. The entire package includes five capsules, with a total activity of 18.5 MBq (500 Ci). The capsule's color is green, and it is utilized in thyroid imaging and function studies. The dosage of the capsule is 0.185 to 3.7 MBq, and it is essential to store it between 15 and 30°C (69:3 and 86°F). To calculate the correct dosage, you can use a color-coded decay calendar. The manufacturer of this radioactive drug is Jubilant Draximage Inc. located at Kirkland, Quebec HOH 4J4 Canada.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.